Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Immunic
IMUX
$195M
| $1.18M | ﹤0.01% |
89,565
+47,804
| +114% | +$621K |
|
3302
Richmond Mutual Bancorp
RMBI
$254M
| $1.18M | ﹤0.01% |
106,121
-927
| -0.9% | -$10.6K |
|
|
SYRS
3303
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.18M | ﹤0.01% |
220,245
+58,682
| +36% | +$406K |
|
3304
Union Bankshares
UNB
$109M
| $1.18M | ﹤0.01% |
38,529
| – | – |
|
3305
OR Royalties Inc
OR
$6.2B
| $1.17M | ﹤0.01% |
70,925
+3,678
| +5% | +$54.3K |
|
3306
5E Advanced Materials
FEAM
$62.3M
| $1.17M | ﹤0.01% |
37,955
+6,970
| +22% | +$219K |
|
|
WMPN
3307
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $1.17M | ﹤0.01% |
94,521
-2,017
| -2% | -$24.7K |
|
3308
AbCellera Biologics
ABCL
$2.12B
| $1.17M | ﹤0.01% |
257,366
+1,222
| +0.5% | +$6.24K |
|
3309
VirTra
VTSI
$34.5M
| $1.17M | ﹤0.01% |
113,375
+6,664
| +6% | +$71.3K |
|
3310
ECB Bancorp
ECBK
$181M
| $1.17M | ﹤0.01% |
89,745
+5,140
| +6% | +$67K |
|
3311
Franklin Financial Services
FRAF
$280M
| $1.16M | ﹤0.01% |
44,385
+4,404
| +11% | +$125K |
|
3312
Greenwich LifeSciences
GLSI
$211M
| $1.16M | ﹤0.01% |
58,244
+11,428
| +24% | +$141K |
|
|
LNAI
3313
Lunai Bioworks
LNAI
$10.9M
| $1.16M | ﹤0.01% |
5,475
+945
| +21% | +$255K |
|
|
ATYR
3314
aTyr Pharma
ATYR
$50.1M
| $1.16M | ﹤0.01% |
595,111
+8,114
| +1% | +$14.2K |
|
|
CMBM
3315
DELISTED
Cambium Networks
CMBM
| $1.16M | ﹤0.01% |
269,192
-312
| -0.1% | -$1.4K |
|
3316
MarketWise
MKTW
$56.6M
| $1.16M | ﹤0.01% |
33,523
+1,855
| +6% | +$78.7K |
|
3317
Intuitive Machines
LUNR
$2.63B
| $1.16M | ﹤0.01% |
185,096
+46,992
| +34% | +$223K |
|
3318
Acumen Pharmaceuticals
ABOS
$176M
| $1.16M | ﹤0.01% |
285,139
+20,536
| +8% | +$77.4K |
|
3319
American Outdoor Brands
AOUT
$157M
| $1.15M | ﹤0.01% |
131,191
| – | – |
|
3320
System1
SST
$17.5M
| $1.15M | ﹤0.01% |
58,757
+8,768
| +18% | +$149K |
|
|
VLD
3321
DELISTED
Velo3D, Inc.
VLD
| $1.15M | ﹤0.01% |
72,158
+16,042
| +29% | +$181K |
|
3322
Virco
VIRC
$96.3M
| $1.15M | ﹤0.01% |
105,203
-1,276
| -1% | -$13.8K |
|
3323
Saga Communications
SGA
$63.9M
| $1.15M | ﹤0.01% |
51,438
-631
| -1% | -$14.6K |
|
|
VIGL
3324
DELISTED
Vigil Neuroscience
VIGL
| $1.14M | ﹤0.01% |
334,242
+18,704
| +6% | +$58.4K |
|
3325
Bilibili
BILI
$7.84B
| $1.13M | ﹤0.01% |
101,136
+390
| +0.4% | +$4.09K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.